---
title: 'INCA033989: the first shot on goal for MPNs?'
date: '2024-11-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39607716/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241128173846&v=2.18.0.post9+e462414
source: Blood
description: In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989,
  that selectively targets mutant calreticulin (mutCALR) in myeloproliferative neoplasms
  (MPNs), inhibiting its oncogenic activity without affecting normal ...
disable_comments: true
---
In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs), inhibiting its oncogenic activity without affecting normal ...